Purdue Pharma bankruptcy plan that shields Sackler family faces Supreme Court review
The U.S. Supreme Court will hear oral arguments Monday about the legality of a $6 billion bankruptcy agreement for Purdue Pharma, the manufacturer of OxyContin. While many families of victims support the deal,